News from acelrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 14, 2015, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Announces Presentation Of Sublingual Sufentanil Data At The Society of American Gastrointestinal and Endoscopic Surgeons Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that a poster presentation will be made at the Annual Society of American...

Mar 20, 2015, 15:00 ET
AcelRx logo.

AcelRx Appoints Howard B. Rosen as Interim CEO

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 16, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Announces Initiation Of Pivotal Phase 3 Trial For ARX-04

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 09, 2015, 16:05 ET
AcelRx logo.

AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 09, 2015, 07:30 ET

AcelRx Provides Regulatory Update on Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Mar 04, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Feb 20, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Feb 04, 2015, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Present at BIO CEO & Investor Conference

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Dec 02, 2014, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Receives CE Mark Approval for Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 20, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate in Four Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 13, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 10, 2014, 16:01 ET
AcelRx logo.

AcelRx Pharmaceuticals Reports Third Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 10, 2014, 07:00 ET

AcelRx Pharmaceuticals Receives International Standards Organization (ISO) 13485:2003 Certification of its Quality Management System

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 07, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Nov 06, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Monday, November 10, 2014

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Nov 05, 2014, 16:00 ET
AcelRx logo

Acelrx Pharmaceuticals Announces Management Change

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Oct 27, 2014, 07:00 ET
AcelRx logo

AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the American College of...

Oct 22, 2014, 07:00 ET
AcelRx logo.

AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that results from the  IAP310 study have been published in Regional...

Oct 16, 2014, 07:00 ET
AcelRx logo.

AcelRx Pharmaceuticals Provides Update on its Patent Portfolio for Zalviso™ and its Proprietary Platform Technologies

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Oct 10, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Announces Multiple Sublingual Sufentanil Data Presentations At The American Society Of Anesthesiologists Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) today announced that multiple moderated poster presentations will be made at the upcoming American...